Silviu Albu

Prof. Silviu Albu

Iuliu Haţieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania
orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
Silviu AlbuSilviu Albu
Silviu Albu
Chronic rhinosinusitis (CRS) is one of the most common chronic medical conditions worldwide, affecting all age groups

1 October 2010 in Otolaryngology–Head and Neck Surgery
Verified
Journal Article
Closed access
Silviu AlbuSilviu Albu
Silviu Albu
AGAnamaria Gocea
Anamaria Gocea
IMIleana Mitre
Ileana Mitre

22 July 2014 in BioMed Research International
Verified
Journal Article
Open access
PDF file
FCFelician Chirtes
Felician Chirtes
Silviu AlbuSilviu Albu
Silviu Albu
Background. Cisplatin is a well known platinum-based chemotherapeutic agent used for the treatment of various malignant tumours. A frequent side effect of cisplatin therapy is ototoxicity. Unfortunately, currently there are no available treatments.Material and Methods. Experimental, clinical studies and reviews published between 2004 and 2014 in the English medical literature concerning ototoxicity were selected using Medline, PubMed, and Google Scholar databases. Inclusion criteria were cisplatin-induced ototoxicity and therapy aimed at preventing or curing this disorder. Molecular mechanisms and clinical, audiological, and histological markers of cisplatin-induced ototoxicity are described. Moreover, experimental and clinical strategies for prevention or treatment of hearing loss were also reviewed.Results and Discussion. Experimental studies demonstrate a wide range of otoprotective molecules and strategies efficient against cisplatin-induced hearing loss. However, only dexamethasone proved a slight otoprotective effect in a clinical study.Conclusion. Further research must be completed to bring future therapeutic options into clinical setting.

1 July 2010 in American Journal of Rhinology & Allergy
Verified
Journal Article
Closed access
Silviu AlbuSilviu Albu
Silviu Albu
Roxana Liana Lucaciu (Stan)Roxana Liana Lucaciu (Stan)
Roxana Liana Lucaciu (Stan)
Background: The study was designed to assess the usefulness of postoperative antibiotics in patients undergoing endoscopic sinus surgery (ESS). Methods: The effects of antibiotics in the postoperative period of ESS patients were evaluated in a prospective, randomized, double-blind, placebo-controlled study. Fifty patients were treated with amoxicillin/clavulanate for 2 weeks after ESS, while the other half received placebo. Preoperatively, the symptom, endoscopic, and CT scores were recorded. In the postoperative period, symptom and endoscopic scores were recorded on the 5th, 12th, 21st, and 30th days. In estimating the length of the blood crust formation episode, a Kaplan-Meier plot was used. Results: Seventy-five patients completed the study: forty in the antibiotic-treated group and thirty-five in the placebo group. On the 5th day, nasal obstruction and drainage were significantly better in the antibiotic-treated group. In addition, a statistically significant difference in the endoscopic scores was noted between the treatment and placebo groups on days 5 and 12. Conclusion: The use of an antibiotic (amoxicillin/clavulanate) in the postoperative period is able to improve the outcome in the early blood crust healing phase: nasal obstruction and drainage are reduced and the endoscopic score objectively showed a faster recovery.

1 June 2012 in Otology & Neurotology
Verified
Journal Article
Closed access
Silviu AlbuSilviu Albu
Silviu Albu
FTFranco Trabalzini
Franco Trabalzini
MAMaurizio Amadori
Maurizio Amadori
The usefulness of cortical mastoidectomy in myringoplasty remains an issue of controversy. We aimed to assess the effectiveness of mastoidectomy on outcomes of tympanoplasty performed in patients with persistent or intermittent discharging chronic suppurative otitis media without cholesteatoma. Prospective, randomized, single-blinded study. Level of evidence-1B. Tertiary referral center. Three hundred twenty consecutive adult patients presenting persistent or intermittent otorrhea during the preceding 6 months scheduled for myringoplasty were included. Patients were randomly assigned to undergo either myringoplasty with cortical mastoidectomy (Group A) or myringoplasty only (Group B). Graft success rate and mean postoperative air-bone gap. Auditory outcomes were evaluated at one year postoperatively. At the end of the follow-up period, there were 24 failures within Group A (success rate, 82.8%) and 34 within Group B (success rate, 76%), statistically not significant. In the univariate analysis, 3 factors were found to be significant in predicting success rate: healthy opposite ear, a long dry period preceding the operation and nonsmoker status. The only factor attaining significance in the multivariate analysis was a dry period longer than 3 months. Cortical mastoidectomy offers no additional benefit in myringoplasty performed on patients with persistent or intermittent discharging CSOM and no evidence of cholesteatoma or mucosal blockage within the antrum.

1 May 2012 in Drug Design, Development and Therapy
Verified
Journal Article
Open access
Silviu AlbuSilviu Albu
Silviu Albu
Peer reviewed article authored by (Albu S). Read article or submit your manuscript for publishing.